Evidence map›Paper›PMID 23169882›Full record

ArticleInvestigative ophthalmology & visual science2012

Ocular surface extracellular DNA and nuclease activity imbalance: a new paradigm for inflammation in dry eye disease.

Snehal Sonawane, Vishakha Khanolkar, Abed Namavari, Shweta Chaudhary, Sonal Gandhi, Sapna Tibrewal, Sarmad H Jassim, Brittany Shaheen, Joelle Hallak, John H Horner and 3 more

4 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 59 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 2 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02193490 phase1 / phase2terminatednot on this mapstarted 2014, after this paper: background citation

Safety and Efficacy Of Recombinant Human Deoxyribonuclease Eye Drops In Patients With Sjogren's and Non-Sjogren Dry Eye Disease

TypeinterventionalSponsorUniversity of Illinois at ChicagoRan2014 to 2017Enrolled47ConditionsDry EyeArmsDNase, Vehicle
NCT02702518 phase1 / phase2terminatednot on this mapstarted 2016, after this paper: background citation

A Phase I/II Randomized Placebo-Controlled, Double-Blind, Single-Center, Tolerability and Preliminary Efficacy Clinical Trial of Recombinant Human Deoxyribonuclease (rhDNase) Eye Drops in Patients With Ocular Graft-Vs.-Host Disease

TypeinterventionalSponsorUniversity of Illinois at ChicagoRan2016 to 2020Enrolled58ConditionsOcular Graft vs Host Disease, Dry EyeArmsrhDNase I, Vehicle
NCT02975557 phase1 / phase2terminatednot on this mapstarted 2016, after this paper: background citation

A Phase I/II Randomized, Placebo-Controlled, Double-Blind, Single-Center, Tolerability And Preliminary Efficacy Study Of Use of Brimonidine Eye Drops for Treatment of Ocular Graft-vs-Host Disease (oGVHD)

TypeinterventionalSponsorSandeep Jain, MDRan2016 to 2017Enrolled15ConditionsDry Eye, Ocular Graft vs Host Disease, Meibomian Gland DysfunctionArmsBrimonidine 0.15%, Brimonidine 0.075%, Placebo
NCT04946721 recruitingnot on this mapstarted 2022, after this paper: background citation

2177GCCC: Identifying Novel Treatment Targets and Biomarkers for Ocular Surface Disease in Patients With Ocular Graft vs Host Disease (oGVHD) a Biobank Study

TypeobservationalSponsorUniversity of Maryland, BaltimoreRan2022 to 2027Enrolled150ConditionsDry Eye Disease, oGVHDArmsThe standard care exam and biological specimens' collection
3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 2 syntheses or guidelines pooled it, 120 citations in OpenAlex.

  1. Role of Neutrophils on the Ocular Surface.International journal of molecular sciences · 2021
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. A GMR enzymatic assay for quantifying nuclease and peptidase activity.Frontiers in bioengineering and biotechnology · 2024
    Article
  17. Exploring the Role ofMolecules (Basel, Switzerland) · 2023
    Article
  18. Article
  19. Ocular surface immune cell diversity in dry eye disease.Indian journal of ophthalmology · 2023
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Snehal SonawaneCorneal Neurobiology Laboratory, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, College of Medicine, Chicago, Illinois 60612, USA.
Vishakha Khanolkar
Abed Namavari
Shweta Chaudhary
Sonal Gandhi
Sapna Tibrewal
Sarmad H Jassim
Brittany Shaheen
Joelle Hallak
John H Horner
Martin Newcomb
Joy Sarkar
Sandeep Jain
University of Illinois Chicago · US

Funding

Translational Core for Therapeutic and Diagnostic DevelopmentP30EY001792 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI YAO, XINCHENG · 1985 to 2025
$14.8M
Keratocyte role in guidance of corneal nervesK08EY018874 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI JAIN, SANDEEP · 2009 to 2013
$1.4M
NEI NIH HHS EY001792NEI NIH HHS EY018874NEI NIH HHS K08 EY018874NEI NIH HHS P30 EY001792
6 · The paper itself

Abstract

purposeWe determined whether nucleases are deficient in the tear fluid of dry eye disease (DED) patients, and whether this causes extracellular DNA (eDNA) and neutrophil extracellular trap (NET) accumulation in the precorneal tear film, thus causing ocular surface inflammation.

methodsExfoliated cells adhered to Schirmer test strips were collected on glass slides, and immunofluorescence confocal microscopy was used to evaluate neutrophils, eDNA, NETs, and their molecular components. Similar experiments were performed with mucoid films collected from the inferior conjunctival fornix or bulbar conjunctiva. We used quantitative PCR to evaluate eDNA signaling pathways and inflammatory cytokine expression. We also determined the amount of ocular surface eDNA and evaluated tear fluid nuclease activity.

resultseDNA, NETs, and neutrophils were present on the ocular surface in DED patients and abundant in mucoid films. NETs consisted of eDNA, histones, cathelicidin, and neutrophil elastase. Tear fluid nuclease activity was decreased significantly in DED patients, whereas the amount of eDNA on the ocular surface was increased significantly. Expression of genes downstream of eDNA signaling, such as TLR9, MyD88, and type I interferon, as well as the inflammatory cytokines interleukin-6 and tumor necrosis factor-α, was significantly increased in DED patients.

conclusionsExtracellular DNA production and clearance mechanisms are dysregulated in DED. Nuclease deficiency in tear fluid allows eDNA and NETs to accumulate in precorneal tear film, and results in ocular surface inflammation. These findings point to novel therapeutic interventions in severe DED based on clearance of eDNA, NETs, and other molecular components from the ocular surface.

Indexed as

Antimicrobial Cationic PeptidesCathelicidinsConjunctivaDeoxyribonuclease IDNADry Eye SyndromesEnzyme-Linked Immunosorbent AssayFluorescence Resonance Energy TransferFluorescent Antibody Technique, IndirectGene ExpressionHistonesHumansLeukocyte ElastaseLipocalin 1Microscopy, ConfocalNeutrophilsAntimicrobial Cationic PeptidesCathelicidinsDeoxyribonuclease IDNAHistonesLeukocyte ElastaseLipocalin 1

Identifiers

PMID23169882
PMCPMC3525138
OpenAlexW2058816841

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.